NCT05787639 2026-05-19Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)University of California, San DiegoPhase 2 Active not recruiting29 enrolled